Lipiodol Press Articles
Journal of Nuclear Medicine, The - ^sup 188^Re-ECD/Lipiodol in Hepatoma Treatment
Posted by admin / Under LipiodolJanuary 1, 2010 -- Luo et al. from the Institute of Nuclear Energy Research (Taoyuan. Taiwan) reported in the October issue of Cancer Biotherapy and...
Journal of Nuclear Medicine, The - Transarterial Injection of ^sup 131^I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer
Posted by admin / Under LipiodolJune 1, 2009 -- Transarterial chemoembolization (TACE) improves survival in patients with hepatocellular carcinoma (HCC) in whom curative therapies are not...
Journal of Nuclear Medicine, The - Promise of Locoregional Radiopharmaceutical Therapy: Will It Ever Be Realized?, The
Posted by admin / Under LipiodolMarch 1, 2008 -- An excellent retrospective review by Boucher et al. in this issue of The Journal of Nuclear Medicine underscores what most of us have accepted as...
Journal of Nuclear Medicine, The - Adjuvant Intraarterial Injection of ^sup 131^I-Labeled Lipiodol After Resection of Hepatocellular Carcinoma: Progress Report of a Case-Control Study with a 5-Year Minimal Follow-up
Posted by admin / Under LipiodolMarch 1, 2008 -- Recurrences after resection of hepatocellular carcinoma are frequent. A single postoperative injection of ^sup 131^I-labeled lipiodol in the...
JCNN News Summaries - Japan Corporate News Network - Terumo Acquires Exclusive Sales Rights for Three Contrast Agents from
Posted by admin / Under LipiodolOctober 17, 2005 -- Tokyo, Oct 17, 2005 - (JCN) - Terumo (TSE: 4543) announced on October 17 that it has signed an exclusive licensing agreement with Guerbet AG, a...
